http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014070038-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43ff28d0ce54baaa39f9a3486917da18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9800bfc7789734b1eaf3c03e033648ac
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-143
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4425
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-00
filingDate 2013-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a57cd13bb0a253f69407d49d193be54b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f284f07bf301c88c1975b2762f94e54c
publicationDate 2014-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2014070038-A1
titleOfInvention Solid dosage form having neuroprotective, antiamnesic, antioxidant, antihypoxic and anti-ischemic activity (variants)
abstract The invention relates to the pharmaceutical industry and the field of medicine and can be used in the creation and administration of solid dosage forms having neuroprotective, antiamnesic, antioxidant, antihypoxic and anti-ischemic activity. The aim of the present invention is to create a solid dosage form having neuroprotective, antiamnesic, antioxidant, antihypoxic and anti-ischemic activity, by means of using 2-ethyl-6-methyl-3-hydroxypyridine succinate, mineral substances, 13 ะก isotopes and 15 N isotopes. The technical results of the invention are a more rapid onset of therapeutic effect, an enhanced therapeutic effect with no increase in the concentration of the 2-ethyl-6-methyl-3-hydroxypyridine succinate preparation, and improved stability for the duration of the shelf life.
priorityDate 2012-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2412188-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2385722-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2156087-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2205640-C1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226554005
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128307740
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227264563
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227870335
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67120752
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID114681
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID122298

Total number of triples: 43.